Ligand validation:7F9T

1XK: 4-[(3S)-3-cyclopropyl-3-(hydroxymethyl)-2-oxidanylidene-pyrrolidin-1-yl]-N-[[3-fluoranyl-5-(1-methylpyrazol-4-yl)phenyl]methyl]-6-methyl-pyridine-2-carboxamide

1XK is a Ligand Of Interest in 7F9T designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7F9T_1XK_B_1001	81%	77%	0.094	0.946	0.34	0.56	-	-	0	0	100%	0.97
7F9T_1XK_A_1001	78%	79%	0.103	0.946	0.29	0.57	-	-	0	0	100%	0.93
7VC3_1XK_A_1001	77%	56%	0.117	0.958	0.95	0.75	2	1	0	0	100%	0.94
7FAM_1XK_A_901	65%	67%	0.141	0.944	0.34	0.9	-	3	0	0	100%	1
7F9A_1XK_A_1901	63%	71%	0.134	0.929	0.34	0.77	-	2	0	0	100%	1
7F97_1XK_B_802	59%	1%	0.186	0.97	4.96	3.87	13	17	2	0	100%	0.95

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.